
- Telehealth Visits
- Insurance plan information

Kate Frometa, CNM
Midwifery- Telehealth Visits
- Insurance plan information



Kate Frometa, CNM
Midwifery- Telehealth Visits
- Insurance plan information
On this page
About me
Kate Frometa is a certified nurse-midwife who specializes in normal pregnancy and birth, well-woman gynecology and centering pregnancy groups.
Frometa received her bachelor's degree in community health at Brown University and her nursing degree at Columbia University. She completed her midwifery training at the University of Rhode Island.
Frometa is a member of the American College of Nurse-Midwives and Mexican Midwifery Association.
Education & training
Board certification
- Nurse Midwife, American Midwifery Certification Board
Degree
- MSN, University of Rhode Island Nurse Midwifery Program
My expertise
Specialties
- Midwifery
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%222196%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222196%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.